Clinical Trials Directory

Trials / Unknown

UnknownNCT01365676

GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms

Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Phytopharm Consulting Brazil · Network
Sex
Female
Age
25 Years – 55 Years
Healthy volunteers
Not accepted

Summary

2 phytomedicines already in the market: GAMALINE® for premenstrual syndrome and HIPERICIN® as antidepressant will be prescribed together for treating women with Premenstrual Syndrome (PMS) symptoms and vasomotor problems for checking the advantage compared to the GAMALINE® prescription alone.

Detailed description

Test with 2 female groups: 25-44 years old (reproductive age) and 45-55 years old (climacteric premenopausal age) complaining about all symptoms related with premenstrual syndrome.

Conditions

Interventions

TypeNameDescription
DRUGGAMALINE® + HIPERICIN®GAMALINE® 900mg + HIPERICIN 300mg T0 = 2 soft caps of each / day (1st month) T1-T6 = 1 soft caps of each / day (2nd - 6th month)
DRUGGAMALINE®GAMALINE® 900mg T0= 2 soft caps / day (1st month) T1-T6 = 1 soft caps / day (2nd - 6th month)

Timeline

Start date
2012-03-01
Primary completion
2012-10-01
Completion
2012-12-01
First posted
2011-06-03
Last updated
2011-12-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01365676. Inclusion in this directory is not an endorsement.